RE:Re: Kensin 1954Tax loss is a possible factor. How much, we don't know for sure but to discount it entirely is wrong, It's a reasonable possibiltiy IMO. Another reasonable possibility Nextleaf is down is due to sector sentiment. Since Nextleaf is a junior stock it's been hit that much harder than the more established stocks like medipharm, valens, neptune etc. I figure many investors bought into Nextleaf thinking it would move up in share price like Labs and Valens did but sentiment in the sector changed that. What occured late 2018 and early 2019 isn't the same reality now. Losses have been big in the mj sector. For example I had shares in Aphria in early 2018 and I sold those for around the $18-$19 range at that time. Look where Aphria is today $6.55 and that's an established company and they have a deal with Shoppers. It's not just us Nextleaf share holders that are in the red, many shareholders accross the board are in the same boat. I have well over 100,000 shares in Nextleaf at .43 per share so I get where you're coming from. I'm disapointed too but there's no conspiracy here, just a massive sector dump intensified by an over bloated Canopy Growth and Peter the "illegal room" Acceto, Can't Trust. It's been a very difficult year for cannabis and there's only so much any CEO can do. Nextleaf just recieved their last piece of machinery days ago. The lead time on custom machines like this is huge so other than a few weeks here and there, Paul did well to get this last piece before the end of the year. Time fram wise medipharm took about 8 months or so from license issue to production and revenue I believe. Nextleaf recieved it's license 4 months ago. It may seem like it's taking a long time because we're sitting in the red but we're on schedule. At the end of the day it get's down to an individual risk tolerance. I've had the opportunity to talk with Paul Pederson by phone and I've had several communications with him and with IR and with others that have talked with Adel. I'm confident with Nextleaf and their future. This is my opinion based upon hours and hours of due dilligence. Any stock is a gamble but marijuanna stocks are an even bigger and more volitile gamble, hence great risk to reward ratio. Patience is the key to Nextleaf.